Infosys, a global leader in consulting and technology, today announced that it has made a commitment to work with the MDG Health Alliance, the United Nations Foundation, and the Clinton Health Access Initiative as an Innovation Partner for the India Public-Private Partnership to End Child Diarrheal Deaths, in support of the United Nations Secretary-General’s Every Woman Every Child movement. Under this program Infosys Labs, the research and innovation arm of Infosys, will institute an Innovation Co-creation Lab to explore ways that technology can be used to solve critical maternal and child health challenges.
Every Woman Every Child is an unprecedented global movement spearheaded by the UN Secretary-General to mobilize and intensify global action to improve the health of women and children. In India, the effort is supported by the India Public‐Private Partnership to End Child Diarrheal Deaths, with a vision to prevent deaths of more than 200,000 children under five years of age every year. This partnership will mobilize public and private sector stakeholders to achieve universal coverage of children in India through the intervention of oral rehydration solution (ORS) and zinc by 2015, thereby playing a critical role in preventing diarrheal deaths.
As Innovation Partner for the India Public-Private Partnership to End Child Diarrheal Deaths, Infosys is collaborating with the MDG Health Alliance, United Nations Foundation and the Clinton Health Access Initiative. The Innovation Co-creation Lab created by Infosys will facilitate the convergence of the initiative's task force members onto a common forum offering tools, platforms, frameworks and processes to organize, manage and assist the co-creational interactions specific to this partnership.
Kathy Calvin, CEO, UN Foundation said, "I commend Infosys on stepping up their commitment to women and children's health by applying their unique strengths to help solve one of India's biggest health challenges."
Subu Goparaju, Senior Vice President and Head-Infosys Labs commented, "The India Public-Private Partnership has the potential to make a significant impact and reduce child deaths caused by diarrhea in India. Technology can play a significant role in enabling and enhancing collaboration between various stakeholders involved in this initiative and contributes towards developing affordable healthcare solutions. Infosys is committed to this cause and will provide a platform to drive joint innovation to develop affordable healthcare solutions for this initiative."
Ray Chambers, UN Secretary-General's Special Envoy for Malaria and Chair, MDG Health Alliance, said, "We will not achieve our global goals for maternal and child health without making significant progress in India, where the greatest numbers of women die in childbirth and the greatest numbers of children die before reaching their fifth birthday."
He further added, "We specifically welcome the commitment of Infosys to help us win the fight against diarrhea, one of the leading killers of children in India and we look forward to harnessing the extraordinary skills, talent and creativity of one of India's leading companies to help us scale up the interventions (oral rehydration products and zinc) that could prevent 90% of child diarrheal deaths."
Infosys Labs, the research and innovation arm of Infosys drives research across the Building Tomorrow's Enterprise mega trends that have the potential to transform client business. Healthcare economy is one of these mega trends which impacts both consumers as well enterprises. One of Infosys Labs' focus areas is addressing the challenge of delivering affordable, preventive and patient centric healthcare.
Many of the world's most successful organizations rely on the 151,000 people of Infosys to deliver measurable business value. Infosys provides business consulting, technology, engineering and outsourcing services to help clients in over 30 countries build tomorrow's enterprise. Mr. N. R. Narayana Murthy, Chairman Emeritus and Founder of Infosys, sits on the Board of Directors of the United Nations Foundation.
For more information about Infosys (NASDAQ: INFY), visit
Certain statements in this release concerning our future growth prospects are forward-looking statements, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding fluctuations in earnings, fluctuations in foreign exchange rates, our ability to manage growth, intense competition in IT services including those factors which may affect our cost advantage, wage increases in India, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, restrictions on immigration, industry segment concentration, our ability to manage our international operations, reduced demand for technology in our key focus areas, disruptions in telecommunication networks or system failures, our ability to successfully complete and integrate potential acquisitions, liability for damages on our service contracts, the success of the companies in which Infosys has made strategic investments, withdrawal or expiration of governmental fiscal incentives, political instability and regional conflicts, legal restrictions on raising capital or acquiring companies outside India, and unauthorized use of our intellectual property and general economic conditions affecting our industry. Additional risks that could affect our future operating results are more fully described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2012 and on Form 6-K for the quarters ended September 30, 2011, December 31, 2011 and June 30, 2012.These filings are available at
www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the company's filings with the Securities and Exchange Commission and our reports to shareholders. The company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the company.
Every Woman Every Child
Launched by UN Secretary-General Ban Ki-moon during the United Nations Millennium Development Goals Summit in September 2010, Every Woman Every Child aims to save the lives of 16 million women and children by 2015. It is an unprecedented global movement that mobilizes and intensifies international and national action by governments, multilaterals, the private sector and civil society to address the major health challenges facing women and children around the world. Every Woman Every Child puts into action the Global Strategy for Women's and Children's Health, which presents a roadmap on how to enhance financing, strengthen policy and improve service on the ground for the most vulnerable women and children.
For more information visit: